FDA Panel Split on Efficacy of Spyral Renal Denervation
The FDA's Circulatory System Devices Panel unanimously agreed that Medtronic's Spyral Renal Denervation device was safe, but the panel was split on its efficacy and whether its benefits outweigh the risks.
Source: medscape.com